Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 2Withdrawn 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Carcinoma, Non-Small-Cell Lung 233Head and Neck Neoplasms 150Squamous Cell Carcinoma of Head and Neck 136Stomach Neoplasms 117Lung Neoplasms 109Esophageal Neoplasms 90Uterine Cervical Neoplasms 72Neoplasms 67Urinary Bladder Neoplasms 56Breast Neoplasms 48Ovarian Neoplasms 46Esophageal Squamous Cell Carcinoma 45Pancreatic Neoplasms 44Small Cell Lung Carcinoma 42Neoplasm Metastasis 40Adenocarcinoma Of Esophagus 38Carcinoma, Squamous Cell 33Carcinoma, Ovarian Epithelial 32Mesothelioma, Malignant 30Parkinson Disease 4, Autosomal Dominant Lewy Body 28Lymphoma 28Adenocarcinoma of Lung 25Sarcoma 24Cholangiocarcinoma 24Nasopharyngeal Carcinoma 22Carcinoma 22Unspecified Adult Solid Tumor, Protocol Specific 21Neuroblastoma 21Gallbladder Neoplasms 21Central Nervous System Neoplasms 21

Interventions

fludarabine phosphate 19Peripheral Blood Stem Cell Transplantation 17Whole-Body Irradiation 15Mycophenolic Acid 14Cyclophosphamide 14Cyclosporine 12Busulfan 12Methotrexate 9Etoposide 9Tacrolimus 8Bortezomib 7Antilymphocyte Serum 7Everolimus 5Dexamethasone 5Vorinostat 4Rituximab 4Panobinostat 4Gemcitabine 4Flow Cytometry 4Carboplatin 4thymoglobulin 3Transplantation 3Therapeutics 3Radiotherapy 3Pharmacogenomic Testing 3Methylprednisolone 3Melphalan 3In Situ Hybridization, Fluorescence 3Gene Expression Profiling 3Early Intervention, Educational 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphoma, Extranodal NK-T-Cell × Cisplatin × Clear all
NCT03246750 2024-04-17

B-MAD Chemotherapy in Newly-diagnosed Extranodal NK/ T-cell Lymphoma

The Thai Lymphoma Study Group

Phase 1/2 Completed
34 enrolled
Lymphoid

Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡